RIM
TMO icon

Redpoint Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Redpoint Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.18M Sell
8,248
-1,749
-17% -$979K 0.61% 29
2022
Q2 		$5.43M Sell
9,997
-60
-0.6% -$33K 0.64% 26
2022
Q1 		$5.94M Buy
10,057
+742
+8% +$426K 0.59% 25
2021
Q4 		$6.21M Sell
9,315
-632
-6% -$395K 0.49% 38
2021
Q3 		$5.68M Sell
9,947
-566
-5% -$311K 0.48% 37
2021
Q2 		$5.3M Sell
10,513
-287
-3% -$135K 0.43% 46
2021
Q1 		$4.93M Buy
10,800
+236
+2% +$113K 0.42% 54
2020
Q4 		$4.92M Buy
10,564
+525
+5% +$246K 0.5% 43
2020
Q3 		$4.43M Sell
10,039
-14,111
-58% -$5.83M 0.48% 51
2020
Q2 		$8.75M Sell
24,150
-1,455
-6% -$488K 0.48% 48
2020
Q1 		$7.26M Sell
25,605
-556
-2% -$175K 0.45% 53
2019
Q4 		$8.5M Sell
26,161
-250
-0.9% -$75.8K 0.41% 53
2019
Q3 		$7.69M Sell
26,411
-552
-2% -$158K 0.41% 53
2019
Q2 		$7.92M Sell
26,963
-1,300
-5% -$358K 0.42% 50
2019
Q1 		$7.74M Hold
28,263
– – 0.39% 56
2018
Q4 		$6.33M Buy
28,263
+468
+2% +$110K 0.37% 62
2018
Q3 		$6.78M Hold
27,795
– – 0.34% 70
2018
Q2 		$5.76M Hold
27,795
– – 0.31% 76
2018
Q1 		$5.74M Hold
27,795
– – 0.32% 73
2017
Q4 		$5.28M Buy
+27,795
New +$5.32M 0.29% 84

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redpoint Investment Management's TMO Position: Q3 2022 in Review

Redpoint Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q3 2022, selling an estimated $979K and leaving 8,248 shares worth $4.18M. The position accounts for 0.61% of the portfolio, ranked #29.

Redpoint Investment Management first reported a position in TMO in Q4 2017 and has held it in 20 quarters since. The position peaked at $8.75M in Q2 2020. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Redpoint Investment Management held 8,248 shares of Thermo Fisher Scientific worth $4.18M as of Q3 2022.
  • Redpoint Investment Management sold 1,749 Thermo Fisher Scientific shares in Q3 2022, an estimated $979K.
  • Thermo Fisher Scientific made up 0.61% of Redpoint Investment Management's portfolio in Q3 2022, its #29 holding.
  • Redpoint Investment Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Thermo Fisher Scientific position peaked at $8.75M in Q2 2020.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.